Not applicableUnknownNCT04191226What this trial is testingGenetic Mutation in Recurrent Cervical CancerWho this might be right forRecurrent Cervical CancerNucleotide VariantCopy Number Variation+6 more Lei Li 300
Not applicableStudy completedNCT03485196What this trial is testingThe Relationship Between Microsatellite Instability and Efficacy of Fluorouracil Based Adjuvant Chemotherapy in Gastric Cancer After OperationWho this might be right forGastric Cancer Affiliated Hospital of Qinghai University 1,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06646445What this trial is testingNeoadjuvant Pembrolizumab With a Watch-and-wait Strategy for dMMR/MSI-H Localized Colon Cancer: PREMICES Study.Who this might be right forColon Cancer GERCOR - Multidisciplinary Oncology Cooperative Group 60
Early research (Phase 1)Study completedNCT03053466What this trial is testingAPL-501 Study for Select Advanced or Relapsed/Recurrent Solid TumorsWho this might be right forSolid TumorMicrosatellite InstabilityMismatch Repair Deficiency+1 more Apollomics (Australia) Pty. Ltd. 30
Not applicableUnknownNCT04122092What this trial is testingEvaluation of Ultrasensitive Chromosomal Aneuploidy Detection for Detecting Minimal Residual Disease in Multiple MyelomaWho this might be right forMultiple Myeloma Shanghai Changzheng Hospital 100
Not applicableUnknownNCT03744962What this trial is testingMSI in Circulatory DNA of Endometrial CancerWho this might be right forMicrosatellite InstabilityLynch SyndromeEndometrial Cancer+1 more Lei Li 100
Not applicableStudy completedNCT07180966What this trial is testingDevelopment and Validation of the Surgical Assessment and Healthcare (SAH) Index for Gastric Cancer Treatment EvaluationWho this might be right forGastric Cancer (GC) Ruijin Hospital 780
Early research (Phase 1)Active Not RecruitingNCT05787587What this trial is testingPARG Inhibitor IDE161 in Participants With Advanced Solid TumorsWho this might be right forAdvanced or Metastatic Solid TumorsBreast CancerOvarian Cancer+6 more IDEAYA Biosciences 216
Not applicableStudy completedNCT06414304What this trial is testingDynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor TherapyWho this might be right forColorectal CancerColorectal Cancer MetastaticMSI-H Colorectal Cancer+3 more OncoAtlas LLC 30
Not applicableStudy completedNCT03047226What this trial is testingDiagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal CancerWho this might be right forLynch Syndrome Second Affiliated Hospital, Zhejiang University, School of Medicine 311
Testing effectiveness (Phase 2)Active Not RecruitingNCT02628067What this trial is testingStudy of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)Who this might be right forAdvanced CancerAnal CarcinomaAnal Cancer+22 more Merck Sharp & Dohme LLC 1,609
Not applicableStudy completedNCT05162248What this trial is testingMicrosatellite Instability in Colorectal CancersWho this might be right forColorectal CancerColorectal CarcinomaMicrosatellite Instability High+2 more Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey 231
Testing effectiveness (Phase 2)Study completedNCT06428487What this trial is testingNeoadjuvant Prolgolimab Monotherapy in Locally Advanced MMR-deficient Colorectal CancerWho this might be right forColorectal Cancer Blokhin's Russian Cancer Research Center 30
Testing effectiveness (Phase 2)Study completedNCT02314481What this trial is testingDeciphering Antitumour Response and Resistance With INtratumour HeterogeneityWho this might be right forNon-small Cell Lung Cancer University College, London 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03607890What this trial is testingStudy of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 InhibitorWho this might be right forRefractory MSI - H Solid Tumors Prior of PD-(L) 1 TherapyMSI-H Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT03428802What this trial is testingPembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic InstabilityWho this might be right forBRCA1 Gene MutationBRCA2 Gene MutationLocally Advanced Solid Neoplasm+17 more Rutgers, The State University of New Jersey 21
Large-scale testing (Phase 3)Looking for participantsNCT05770102What this trial is testingDETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) DispositionWho this might be right forMalignancyMalignant NeoplasmLymphoproliferative Disorders+7 more Cancer Research UK 30
Post-approval studies (Phase 4)UnknownNCT03109119What this trial is testingDoes Sevoflurane Cause Genomic DamageWho this might be right forAnesthesia; Adverse Effect Jubilee Mission Medical College and Research Institute 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04006262What this trial is testingPre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma.Who this might be right forLocalized Oesogastric AdenocarcimonaMSI and or dMMR GERCOR - Multidisciplinary Oncology Cooperative Group 32
Not applicableUnknownNCT05058937What this trial is testingExamine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer CentreWho this might be right forSolid TumorMetastatic Cancer The Belgian Society of Medical Oncology 936